-

Bruker Launches Revolutionary High-Speed AFM System for Single-Molecule Applications

JPK NanoRacer® Follows Molecular Dynamics in Real Time at 50 Frames per Second

BERLIN--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the release of the NanoRacer high-speed AFM system. With an unprecedented imaging speed of 50 frames per second, this sets a new milestone in high-speed scanning capabilities to enable true real-time visualization of dynamic biological processes using atomic force microscopy (AFM). Developed in close collaboration with leading experts in the field, the NanoRacer also delivers atomic resolution and unmatched user friendliness, and it is expected to provide crucial insights into single-molecule behavior and an in-depth understanding of dynamic processes in biochemistry, molecular biology, and biomedicine.

“So many things are still hidden in biological molecules,” stated Toshio Ando, Professor at the Nano Life Science Institute (WPI-NanoLSI) of Kanazawa University in Japan. “To uncover their unexplored secrets, there is a true need to directly observe individual molecules during their functional activity. As the fastest commercial, high-speed AFM available, the NanoRacer enables this direct observation in real-time. A lot of innovative ideas have been incorporated for easy operation and high performance, and it is my utmost wish that many researchers will use the NanoRacer to make exciting discoveries.”

“The NanoRacer system is the satisfying culmination of a series of Bruker innovations in high-speed AFM,” added Torsten Jähnke, Bruker’s Director of BioAFM. “From both a performance and usability standpoint, we believe the NanoRacer will revolutionize high-end atomic force microscopy for single-molecule applications. Researchers from biochemistry, molecular biology, and molecular medicine now have, for the first time, an AFM tool that enables them to watch molecules at work and understand structure-function relationships in depth.”

About the JPK NanoRacer High-Speed AFM
The NanoRacer system is designed for use with small cantilevers. It can achieve top speeds of 50 frames/sec in fluid, in a 100nm x 100nm scan range, and with 10k pixels. Equipped with photothermal cantilever excitation, a new XYZ flexure scanner architecture, and lowest noise positioning sensors in each axis, the NanoRacer sets a new benchmark for high-end research AFM capabilities. Lowest forces and highest resolution, combined with utmost stability, make it a powerhouse for advanced applications and discoveries on the molecular scale. The new system also incorporates JPK’s high-performance Vortis™ 2 controller and intuitive software user interface for superior ease-of-use operation. The fully automated setup capabilities allow researchers to focus on their experiments, making the NanoRacer system perfect for multi-user environments or imaging facilities.

About the JPK BioAFM Business
JPK joined Bruker in July 2018, bringing in-depth expertise in live-cell imaging, cellular mechanics, adhesion, and molecular force measurements, optical trapping, and biological stimulus-response characterization to Bruker’s worldwide infrastructure and established instrumentation development and support. The JPK BioAFM business takes full advantage of the best of both histories to provide microscopy instrumentation for biomolecular and cellular imaging, as well as force measurements on single molecules, cells and tissues. To learn more about Bruker’s biological research AFMs, please visit: www.bruker.com/BioAFM.

About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.

Contacts

Investor Contact:
Miroslava Minkova
Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663-3660 x1479
E: Investor.Relations@bruker.com

Media Contact:
Dr. Gabriela Bagordo
Communications Manager BioAFM
Bruker Nano GmbH
T: +49 (30) 726243 500
E: Gabriela.Bagordo@bruker.com

Bruker Corporation

NASDAQ:BRKR

Release Summary
Bruker Launches Revolutionary High-Speed AFM System for Single-Molecule Applications
Release Versions

Contacts

Investor Contact:
Miroslava Minkova
Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663-3660 x1479
E: Investor.Relations@bruker.com

Media Contact:
Dr. Gabriela Bagordo
Communications Manager BioAFM
Bruker Nano GmbH
T: +49 (30) 726243 500
E: Gabriela.Bagordo@bruker.com

More News From Bruker Corporation

Bruker Corporation to Present at Upcoming Investor Conferences

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences: Wells Fargo 21st Annual Healthcare Conference in Boston, MA Wednesday, September 9, 2026 at 8:00 a.m. Eastern Time Morgan Stanley 24th Annual Global Healthcare Conference in New York City Wednesday, September 16, 2026, at 10:45 a.m. Eastern Time Bank of America Global Healthcare Conference in London, UK Tuesday, September 22, 2026, at 6:45 a....

BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion

HANAU, Germany--(BUSINESS WIRE)--Bruker Energy & Supercon Technologies (BEST), a segment of Bruker Corporation (Nasdaq: BRKR), and Luvata Materials & Solutions, a Business Unit of Luvata Group (LUVATA) today announced a strategic collaboration to support the rapidly growing demand for superconducting materials and technologies required by next-generation magnetic confinement fusion power demonstration plant projects worldwide.The BEST-LUVATA collaboration aims to further strengthen and e...

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

BOSTON--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced an expanded strategic collaboration with Atinary Technologies Inc., the pioneer of Self-Driving Labs® technologies and AI-driven R&D with applications in pharmaceuticals, chemicals, energy, and materials. Bruker also made a minority investment in Atinary. Financial details were not disclosed. Atinary intends to integrate Chemspeed configurable laboratory automation platforms, Bruker analytical instruments and SciY sc...
Back to Newsroom